TABLE II.
Frequency of female sterilization and reversible prescription contraceptive method use among privately-insured women aged 15–44 years with and without congenital heart defects (CHD), by presence of any CHD and by CHD severity, United States – 2014
| Severity of CHD* | |||||
|---|---|---|---|---|---|
| Non-Severe | |||||
| Tier I | Female sterilization§, || | 247 (3.8%) | 48,189 (2.3%) | 25 (2.2%) | 222 (4.1%) |
| IUD§ | 537 (8.2%) | 124,451 (6.0%) | 83 (7.1%) | 454 (8.4%) | |
| Implant | 87 (1.3%) | 23,605 (1.2%) | 17 (1.5%) | 70 (1.3%) | |
| Tier II | DMPA injectable§ | 184 (2.8%) | 39,584 (1.9%) | 39 (3.4%) | 145 (2.7%) |
| Any oral contraception‡, § | 1,614 (24.6%) | 537,734 (26.1%) | 284 (24.4%) | 1,330 (24.6%) | |
| Progestin-only pill§, || | 144 (2.2%) | 20,770 (1.0%) | 41 (3.5%) | 103 (1.9%) | |
| Combined oral contraception§ | 1,504 (22.9%) | 523,006 (25.4%) | 249 (21.4%) | 1,255 (23.3%) | |
| Patch§ | 34 (0.5%) | 7,470 (0.4%) | 8 (0.7%) | 26 (0.5%) | |
| Ring§ | 82 (1.3%) | 35,413 (1.7%) | 10 (0.9%) | 72 (1.3%) | |
CHD = congenital heart defect; IUD = intrauterine device; DMPA = depot medroxyprogesterone acetate. Data are N= 2,067,554 (100%).
Women with ≥1 inpatient codes for a CHD or ≥2 outpatient codes for a CHD separated by >30 days identified in the inpatient or outpatient services claims from 2011–2014.
For each contraceptive method, the number and percentage of women displayed indicates use of the individual type of contraceptive method. Women are counted as users for each method for which they had a claim during the specified algorithm period for each contraceptive method (female sterilization, IUD, implant: 2011– 2014; injectables, oral contraception, patches, ring: 2014);
Includes codes for a progestin-only pill, combined oral contraception, and oral contraception, type not otherwise specified;
Chi-square test for the use of the individual type of contraceptive method by presence of any CHD was statistically significant at p < .05.
Chi-square test for the use of the individual type of contraceptive method by CHD severity was statistically significant at p < .05.